These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. The immunomodulatory effects of topiramate on azoxymethane-induced colon carcinogenesis in rats: The role of the inflammatory cascade, vascular endothelial growth factor, AKT/mTOR/MAP kinase signaling and the apoptotic markers. Kabel AM; Ashour AM; Ali DA; Arab HH Int Immunopharmacol; 2021 Sep; 98():107830. PubMed ID: 34118646 [TBL] [Abstract][Full Text] [Related]
50. Chemopreventive effect of 2-(allylthio)pyrazine (2-AP) on rat colon carcinogenesis induced by azoxymethane (AOM). Kim DJ; Kang JS; Ahn B; Kim KS; Park KH; Choi KS; Surh YJ; Kim ND Cancer Lett; 2001 May; 166(2):125-33. PubMed ID: 11311484 [TBL] [Abstract][Full Text] [Related]
51. Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer. Raju J World J Gastroenterol; 2008 Nov; 14(43):6632-5. PubMed ID: 19034964 [TBL] [Abstract][Full Text] [Related]
52. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats. Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582 [TBL] [Abstract][Full Text] [Related]
54. Advanced glycation end products (AGE) induce the receptor for AGE in the colonic mucosa of azoxymethane-injected Fischer 344 rats fed with a high-linoleic acid and high-glucose diet. Shimomoto T; Luo Y; Ohmori H; Chihara Y; Fujii K; Sasahira T; Denda A; Kuniyasu H J Gastroenterol; 2012 Oct; 47(10):1073-83. PubMed ID: 22467055 [TBL] [Abstract][Full Text] [Related]
55. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057 [TBL] [Abstract][Full Text] [Related]
56. Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats. Carroll RE; Goodlad RA; Poole AJ; Tyner AL; Robey RB; Swanson SM; Unterman TG Growth Horm IGF Res; 2009 Oct; 19(5):447-56. PubMed ID: 19406679 [TBL] [Abstract][Full Text] [Related]
57. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen. Whiteley LO; Hudson L; Pretlow TP Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294 [TBL] [Abstract][Full Text] [Related]